
Cagent Vascular
Developing innovative intravascular lithotripsy technology for treating calcified peripheral artery disease.
About
Cagent Vascular, Inc. is a medical device company focused on developing and commercializing innovative intravascular lithotripsy (IVL) technology. Their flagship product, the Serranator SONIC IVL System, is designed to treat calcified lesions in peripheral arteries, a common and challenging condition in patients with Critical Limb Ischemia (CLI).
Similar companies
Developing wearable brain imaging systems using quantum sensing technology.
Shares Medical Devices, Biotechnology
Redefining kidney stone treatment with an aspiration-based stone removal system.
Shares Medical Devices, Biotechnology
Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes.
Shares Medical Devices, Healthcare
Developing a minimally invasive, one-time outpatient therapy for obesity treatment.
Shares Medical Devices, Biotechnology
Revolutionizing the treatment of thromboembolic disease through innovative medical technology and connected care solutions.
Shares Medical Devices, Biotechnology
Developing innovative, minimally invasive solutions for tricuspid valve disease treatment.
Shares Medical Devices, Biotechnology
Key facts
- Website
- cagentvascular.com
- Headquarters
- Wayne, Pennsylvania, USA
- Founded
- 2015
- Total funding
- $41M (Series D)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 19 May 2026 | Series D | $41M |
Tech stack
Detected on cagentvascular.com, last scanned 29 Oct 2026. Run your own scan
- Analytics
- Google Analytics 4, Google Tag Manager
- CMS / Builders
- Squarespace
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Email marketing
- Salesforce Pardot
Cagent Vascular scores 26. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
What does Cagent Vascular do?
The company recently announced the completion of its first human-use cases with the Serranator SONIC IVL System and secured $41 million in Series D funding.
Is Cagent Vascular trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Cagent Vascular is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Cagent Vascular raised?
Cagent Vascular has raised a total of $41M in funding. The most recent round on record is Series D.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Cagent Vascular


